All treatments
Treatment
Fludarabine (Non-IMP, Lymphodepletion) clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingPHASE1
Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
This study is testing a new treatment called Allo-RevCAR01-T-CD123 for adults with a type of blood cancer called Acute Myeloid Leukaemia (AML) that has come back or isn't responding to other treatments. It’s a very early-stage trial (Phase 1) to check if the treatment is safe.
For: Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia RefractoryGermany · Netherlands - RecruitingPHASE1, PHASE2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
This study tests a new 'off-the-shelf' CAR-T cell therapy, Allo-QuadCAR01-T, for hard-to-treat B-cell cancers like lymphoma. It uses donor cells that target two cancer markers, aiming to be faster and potentially more effective than current treatments. Researchers will check its safety and how well it works.
For: Lymphoma Diffuse Large B-cell · Leukemia and Lymphoma · Leukemia RelapseUnited States · Germany